Skip to main content

Table 3 Device compression and compression rate in patients with peri-device leakage

From: Cerebrovascular events, bleeding complications and device related thrombi in atrial fibrillation patients with chronic kidney disease and left atrial appendage closure with the WATCHMAN™ device

 

post-Implantation

at six weeks

at six months

 

No

Yes

p

No

Yes

p

No

Yes

p

DCmax

1.30 ± 0.14

1.27 ± 0.10

0.21

1,29 ± 0.15

1.30 ± 0.11

0.65

1.29 ± 0.15

1.29 ± 0.10

0.93

DCmin

1.20 ± 0.12

1.20 ± 0.10

0.91

1.19 ± 0.12

1.21 ± 0.11

0.50

1.20 ± 0.13

1.20 ± 0.11

0.93

CRmax

1.50 ± 0.22

1.40 ± 0.18

0.02

1.49 ± 0.23

1.41 ± 0.18

0.12

1.49 ± 0.23

1.41 ± 0.15

0.10

CRmin

1.24 ± 0.18

1.18 ± 0.15

0.07

1.24 ± 0.20

1.20 ± 0.13

0.26

1.23 ± 0.18

1.22 ± 0.15

0.29

  1. DCmax = (nominal device size / minimal device diameter), DCmin = (nominal device size / maximal device diameter) CRmax = (nominal device size / minimal LAA ostium diameter), CRmin = (nominal device size / maximal LAA ostium diameter)